Technology | August 30, 2010

Cardiac Mapping System Launched in Japan

August 30, 2010 - A system was released in Japan last week that helps guide treatment of cardiac arrhythmias by creating a 3-D cardiac map and model based on the information from electrophysiology (EP) catheters.

St. Jude Medical is launching its EnSite Velocity Cardiac Mapping System. Advancements in the technology of both the hardware and software for the EnSite Velocity System were designed to increase procedural Cardiac Mapping System Launched in Japan, increase efficiency and speed, and potentially improve ease of use from set-up and operation to clinical application.

The new system hardware requires less space, offers a simpler set-up, using color-coding for each connector, and has an increased number of input channels. The software offers a completely re-designed and user friendly user interface that has two highly differentiated new capabilities:

OneMap Tool

The new OneMap tool allows physicians to create a detailed cardiac model and electrical map together using information from multiple catheters and electrodes. This feature offers the potential to assist physicians in collecting and displaying a greater amount of information in a shorter amount of time.

RealReview Function

The new RealReview function provides real-time, side-by-side views of the live procedure and previously recorded portions of the procedure. This enables physicians to view a quick and easy comparison of events and results at different times throughout the procedure without losing the ability to visualize and navigate catheters in real-time.

Because of the real time ability to display catheter location, the system has the longstanding ability to reduce fluoroscopy exposure. It also supports both contact and non-contact mapping, giving the EnSite Velocity System the ability to map any arrhythmia. The system’s open platform, offers compatibility with essentially all diagnostic and ablation catheters, recording systems and radiofrequency generators used for cardiac ablation procedures.

For more information: www.sjm.com

Related Content

Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News | Ablation Systems | May 16, 2019
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter...
CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News | Ablation Systems | May 16, 2019
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3...
New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias
News | Ablation Systems | May 14, 2019
The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an international consensus...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Ablation Systems | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Ablation Systems | May 10, 2019 | Dave Fornell, Editor
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
Ablation Reduces Risk of Dementia in Patients With AFib and Carotid Artery Disease
News | Ablation Systems | May 08, 2019
Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new research finds it...
CardioFocus Announces European CE Mark Approval Of HeartLight X3 System
News | Ablation Systems | April 16, 2019
CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System.
First Patient Treated With QDot Micro Ablation Catheter
News | Ablation Systems | February 04, 2019
Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study...
FDA Approves TactiCath Contact Force Ablation Catheter, Sensor Enabled
Technology | Ablation Systems | January 21, 2019
Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter,...
First Patient Treated in STELLAR Atrial Fibrillation IDE Study
News | Ablation Systems | November 30, 2018
Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and treated the first...
Overlay Init